Skip Header

13 results for author:"Gingras M.-C." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (5)

PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform.

Liu S.H., Rao D.D., Nemunaitis J., Senzer N., Zhou G., Dawson D., Gingras M.C., Wang Z., Gibbs R., Norman M. et al.

PLoS ONE 7:e40452-e40452(2012) · Mapped (1)

Mutations in KAT6B, encoding a histone acetyltransferase, cause Genitopatellar syndrome.

Campeau P.M., Kim J.C., Lu J.T., Schwartzentruber J.A., Abdul-Rahman O.A., Schlaubitz S., Murdock D.M., Jiang M.M., Lammer E.J., Enns G.M. et al.

Am. J. Hum. Genet. 90:282-289(2012) · UniProtKB (1) · Mapped (3)

Genomic sequencing of key genes in mouse pancreatic cancer cells.

Wang Y., Zhang Y., Yang J., Ni X., Liu S., Li Z., Hodges S.E., Fisher W.E., Brunicardi F.C., Gibbs R.A. et al.

Curr. Mol. Med. 12:331-341(2012) · Mapped (30)

Single nucleotide polymorphism in RECQL and survival in resectable pancreatic adenocarcinoma.

Cotton R.T., Li D., Scherer S.E., Muzny D.M., Hodges S.E., Catania R.L., Witkiewicz A.K., Brody J.R., Kennedy E.P., Yeo C.J. et al.

HPB (Oxford) 11:435-444(2009) · Mapped (6)

Expression analysis and essential role of the putative tyrosine phosphatase His-domain-containing protein tyrosine phosphatase (HD-PTP).

Gingras M.C., Kharitidi D., Chenard V., Uetani N., Bouchard M., Tremblay M.L., Pause A.

Int. J. Dev. Biol. 53:1069-1074(2009) · Mapped (15)

HD-PTP is a catalytically inactive tyrosine phosphatase due to a conserved divergence in its phosphatase domain.

Gingras M.C., Zhang Y.L., Kharitidi D., Barr A.J., Knapp S., Tremblay M.L., Pause A.

PLoS ONE 4:e5105-e5105(2009) · Mapped (4)

Microarray analysis of somatostatin receptor 5-regulated gene expression profiles in murine pancreas.

Patel S.G., Zhou G., Liu S.H., Li M., Jeong J.W., DeMayo F.J., Gingras M.C., Gibbs R.A., Fisher W.E., Brunicardi F.C.

World J Surg 33:630-637(2009) · Mapped (5)

PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer.

Liu S., Ballian N., Belaguli N.S., Patel S., Li M., Templeton N.S., Gingras M.C., Gibbs R., Fisher W., Brunicardi F.C.

Pancreas 37:210-220(2008) · Mapped (1)

Activation of adenovirus type 2 early region 4 ORF4 cytoplasmic death function by direct binding to Src kinase domain.

Champagne C., Landry M.C., Gingras M.C., Lavoie J.N.

J. Biol. Chem. 279:25905-25915(2004) · UniProtKB (1)

TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development.

Gingras M.-C., Lapillonne H., Margolin J.F.

Mol. Immunol. 38:817-824(2002) · UniProtKB (2)

Cytoplasmic death signal triggered by SRC-mediated phosphorylation of the adenovirus E4orf4 protein.

Gingras M.C., Champagne C., Roy M., Lavoie J.N.

Mol. Cell. Biol. 22:41-56(2002) · UniProtKB (1)

CFFM4: a new member of the CD20/Fc-epsilon-RI-beta-family.

Gingras M.-C., Lapillonne H., Margolin J.F.

Immunogenetics 53:468-476(2001) · UniProtKB (1)

Adenovirus E4 open reading frame 4-induced apoptosis involves dysregulation of Src family kinases.

Lavoie J.N., Champagne C., Gingras M.C., Robert A.

J. Cell Biol. 150:1037-1056(2000) · UniProtKB (1)

to top of page·

Page 1 of 1